Chugai Pharmaceutical: Consolidated financial results for the 1st quarter of the fiscal year ending 2025/12 [IFRS] supplementary materials

JPX04:00 ET · Announcements

Chugai Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [IFRS] (consolidated)

JPX04:00 ET · Announcements

Chugai Pharmaceutical 1Q Net Y97.23B Vs Net Y74.40B

Dow Jones04:00 ET

Jefferies Adjusts Chugai Pharmaceutical's Price Target to 8,400 Yen From 7,700 Yen, Keeps at Hold

MT Newswires03:51 ET · Ratings

＜Today's main economic Indicators and schedule＞ L Create is going public, U.S. March existing Residence sales, ETC.

【Domestic】・ 8:30 March corporate service price index ・ 8:50 Weekly foreign and domestic securities trading contracts ・ 2-year government bond auction ・ Earnings Reports = Chugai Pharmaceutical <4519.T>, Canon Inc-Spons Adr <7751.T>, NRI <4307.T>, Nidec Corporation Sponsored ADR <6594.T> ・ IPO (new listing) = LIFE CREATE (L Create) <352A.T> (Growth) 【Overseas】 (Times are Japan time) ・ 17:00 German April Ifo business climate index ・ 21:30 U.S. March durable goods orders, U.S. weekly.

Kabushiki Shimbun18:38 ET

Concerns about the escalation of trade friction between the US and China eased, temporarily recovering to the 35,000 yen range.

The Nikkei Average has made a significant rebound for the first time in three days, closing at 34,868.63 yen, up 648.03 yen (with the estimated Volume of 1.8 billion shares). On the 22nd, in the USA, it was reported that U.S. Treasury Secretary Yellen indicated that progress in trade negotiations with China was possible, leading major stock indices to rise by over 2%. In line with this trend, the Nikkei average started on a Buy and quickly climbed to 35,142.12 yen shortly after the trading began. However, it briefly fell by 143 yen in the morning.

Fisco JapanApr 23 03:26 ET